Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures
Clinical trial NCT03361137 · TERMINATED
Trial details
- NCT number
- NCT03361137
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-28
- Primary completion
- 2020-03-13
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.